Clinical and coronary angiographic characteristics of patients with coronary slow flow

Acta Cardiologica

Volumn 63, Issue 5, 2008, Pages 579-584

  Yilmaz, Hüseyin ^a   Demir, Ibrahim ^a   Uyar, Zehra ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Angiography; Body mass index; Coronary atherosclerosis; Obesity; Slow coronary flow

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IOPROMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; SYSTOLIC BLOOD PRESSURE;

BLOOD FLOW VELOCITY; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 56049096519     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.5.2033224     Document Type: Article

References (39)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7: 479-83.
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries - a new angiographic finding. Am Heart J 1972; 84: 66-71.
3. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell'Italia U, Scibilia G, Motta P, Campa PP. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-81.
4. Rim SJ, Leong-Poi H, Lindner JR, Wei K, Fisher NG, Kaul S. Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation 2001; 104: 2704-9.
5. Camsari A, Pekdemir H, Ciçek D, Katircibasi T, Parmaksiz T, Doven O, Cin VG. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003; 67: 1022-8.
6. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-72.
7. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
8. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-52.
9. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct amgiographic subgroup in syndrome X. Angiology 2001; 52: 507-14.
10. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, Chaitman B, Williams DO, Braunwald E. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial). Am J Cardiol 1994; 74: 531-7.
11. Epstein SE, Cannon O, Talbot TL. Hemodynamic principles in the control of coronary blood flow. Am J Cardiol 1985; 56: 4E-10E.
12. Levin ER. Endothelins. N Engl J Med 1995; 333: 356-63.
13. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
14. Cardillo C, Kilcoyne CM, Cannon RO 3rd, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000; 35: 1237-41.
15. Beltrame JF, Turner SP, Horowitz JD. Persistence of the coronary slow flow phenomenon. Am J Cardiol 2001; 88: 938.
16. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol 2004; 44: 57-62.
17. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol 1995; 26: 41-9.
18. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998; 32 (Suppl 3): S54-61.
19. Sezgin AT, Barutcu I, Sezgin N, Gullu H, Esen AM, Acikgoz N, Topal E, Ozdemir R. Contribution of plasma lipid disturbances to vascular endothelial function in patients with slow coronary flow. Angiology 2006 Dec-2007 Jan; 57: 694-701.
20. Erbay AR, Turhan H, Yasar AS, Bicer A, Senen K, Sasmaz H, Sabah I, Yetkin E. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005; 102: 419-23.
21. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R. Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol 2005; 101: 143-5.
22. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87: 777-9.
23. Pekdemir H, Cm VG, Cicek D, Camsari A, Akkus N, Doven O, Parmaksiz HT. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004; 59: 127-33.
24. Chilian WM, Layne SM, Klausher EC, Eastham CL, Marcus ML. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 1989; 256: 383-90.
25. Zeiher AM, Schachinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994; 89: 2525-32.
26. Binak E, Gunduz H, Sahin M, Kurtoglu N, Dindar I. The relation between impaired glucose tolerance and slow coronary flow. Int J Cardiol 2006; 111: 142-6. Epub 2005 Nov 16.
27. Turhan H, Erbay AR, Yasar AS, Bicer A, Sasmaz H, Yetkin E. Impaired coronary blood flow in patients with metabolic syndrome: documented by thrombolysis in myocardial infarction (TIMI) frame count method. Am Heart J 2004; 148: 789-94.
28. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
29. Al Suwaidi J, Higano ST, Holmes DR, Jr., Lennon R, and Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001; 37: 1523-8.
30. Hutley L, Prins JB. Fat as an endocrine organ: Relationship to the metabolic syndrome. Am J Med Sci 2005; 330: 280e9.
31. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-76.
32. Ritchie SA, Ewart MA, Perry CG, Connell JM, Salt IP. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond) 2004; 107: 519-32.
33. Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-5.
34. Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C. Tumour necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 2003; 108: 1815-21.
35. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
36. Goldstein BJ, Scalia R. Adiponectin. A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-8.
37. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu F, Rinim E. Plasma adiponectin and risk of myocardial infarction in men. JAMA 2004; 291: 1730-7.
38. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.
39. Toikka JO, Ahotupa M, Viikari JS, Niinikoski H, Taskinen M, Irjala K, Hartiala JJ, Raitakari OT. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL oxidation in healthy young men. Atherosclerosis 1999; 147: 133-8.